Understanding Stone Clinical.
A clear introduction to Stone Clinical Laboratories, the laboratory services it described, and the milestones in its public record.
Rooted in diagnostics.
Built around service.
Stone Clinical Laboratories was established in New Orleans and became known for clinical reference laboratory services, with particular emphasis on molecular and preventive diagnostics.
Company materials published under the STONE Diagnostics name describe laboratory testing, technology integration, and service models for both traditional clinical settings and on-site operations.
In October 2025, Fibronostics announced it had acquired Stone Clinical Laboratories, citing laboratory expertise and U.S. infrastructure as complementary to its work in liver and metabolic diagnostics.
Find current information directly through STONE Diagnostics.
What the laboratory worked on.
Areas described in public company materials; services and availability may change.
Molecular testing
PCR-based techniques for detecting infectious diseases and analyzing DNA/RNA targets.
Core clinical testing
Published offerings included chemistry, hematology, microbiology and other reference testing.
Specialized testing
Historical materials include pharmacogenetics and prescription drug monitoring among supported disciplines.
Operational solutions
Mobile testing, reporting technology, integration and support services for care providers and organizations.
Explore primary sources.
The links below lead to the company website, an independent organizational profile and the 2025 acquisition announcement.